Pharma

astrazeneca-s-new-usd500-million-headquarters-will-be-located-at-the-south-of-cambridge

AstraZeneca to move HQ to $500 mn home in Cambridge

  • Europe
  • |
  • News

Singapore: AstraZeneca is looking to move its research and global headquarters to Cambridge, UK, and has zeroed in on a site located at the south of the city. The firm's new headquarters is expected to be worth $500 million and will also... Read more

amgen-beta-pharmaceuticals-will-bring-colon-cancer-drug-vectibix-to-the-chinese-market

Amgen forms JV to launch cancer drug in China


  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US-based Amgen is going to enter into a joint venture with Chinese pharmaceutical firm Zhejiang Beta Pharma, in... Read more

with-arms-wide-open-saudi-arabia-s-modern-healthcare-solutions-welcomes-malaysia-s-pharmaniaga-to-setup-a-pharmaceutical-manufacturing-plant-in-sudair-economic-city-in-riyadh

Malaysian pharma giant to setup plant in Saudi Arabia...


  • Malaysia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Malaysia-based Pharmaniaga has entered into a collaboration with Saudi Arabia-based Modern Healthcare Solutions... Read more

patrys-cancer-drug-gives-hope-to-patients

Patrys cancer drug gives hope to patients

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Patrys, a clinical stage biopharmaceutical company, has confirmed anti-cancer properties of PAT-SM6 and has demonstrated the... Read more

chinese-and-hong-kong-researchers-develop-map-of-avian-influenza-h7n9-comprising-of-bird-migration-patterns-and-estimations-of-poultry-production-and-consumption

Chinese, Hong Kong scientists map H7N9 risk infection

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A map of avian influenza (H7N9), comprising of bird migration patterns and estimations of poultry production and consumption,... Read more

the-debate-still-continues-where-is-india-lacking-on-the-regulatory-front

What can India do to streamline its regulatory processes?

  • India
  • |
  • Analysis
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

India's growing ability to innovate and provide efficient and cost-effective solutions to various bioscience problems plaguing the nation... Read more

dr-smita-singhania-consultant-getz-pharma-india-and-natco-pharma-india-and-director-symbiosis-school-of-biomedical-sciences-symbiosis-international-university-pune-india

Smita Singhania: Avoid 'made-in-India' bias in quality approvals

  • India
  • |
  • Opinion
  • |
  • By Rahul Koul
  • |
  • 0 Comment

The Central Drugs Standard Control Organization and Department of Biotechnology mutually formed and implemented the national regulatory... Read more

the-acquisition-combines-inviragen-s-expertise-in-viral-vaccine-r-d-and-takeda-s-resources-product-development-expertise-and-global-reach

Novartis: Lucentis reduces AMD blindness by 50%

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Novartis revealed new clinical data associated with the eye drug Lucentis (ranibizumab) admist a total of 209 abstracts from... Read more

concert-pharma-and-celgene-s-strategic-collaboration-is-directed-towards-deuterium-modified-compounds-targeting-cancer-and-inflammation

Concert Pharma, Celgene enter in $300 mn merger

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Concert Pharmaceuticals entered into a strategic collaboration with Celgene Corporation directed towards deuterium-modified compounds... Read more

japan-based-irom-holdings-will-acquire-18

Japanese I’rom acquires 18% in Australian IDT

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Japanese company I'rom Holdings will acquire an 18.8 percent stake in IDT Australia. I'rom is listed on the Tokyo Stock Exchange... Read more

in-the-line-of-fire-pawan-bansal-s-family-run-pharma-business-may-now-be-under-scanner

Pawan Bansal's family-run pharma firm also involved in scams?

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

New Delhi: It seems like the troubles for India's Union Cabinet Minister for Railways, Mr Pawan Kumar Bansal, may not have subsided yet.... Read more

us-fda-designates-abbvie-s-hepatitis-c-treatment-as-breakthrough-therapy

FDA: AbbVie Hepatitis therapy is a 'breakthrough'

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: AbbVie's investigational direct-acting antiviral (DAA) combination with and without ribavirin for the treatment of genotype (GT1)... Read more

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X